Research reveals how herpes simplex virus-1 may contribute to Alzheimer’s disease, offering new insights into the disease’s ...

A new study found a link between cytomegalovirus (CMV) and Alzheimer's disease. Here's what a neurologist wants you to know, ...

A new blood test may be key to uncovering new Alzheimer's disease therapies, allowing patients to be treated before the ...

Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease ...

Alzheimer’s disease research is driving entrepreneurship in the Capital Region.

Cognitive profiles for early diagnosis of Dementia with Lewy bodies (DLB) have been outlined in a new study, out today in ...

There’s intriguing news today about a technology that could improve treatment in people with Alzheimer’s. It uses sound waves ...

Alzheimer’s disease could be diagnosed up to a decade earlier after the world’s biggest study of proteins is completed. The ...

Truist raised the firm’s price target on Axsome Therapeutics (AXSM) to $180 from $150 and keeps a Buy rating on the shares. After having spoken ...

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

Tombot has designed a robotic puppy to aid individuals, families and communities in dealing with health adversities. It was ...